Thomas DiRaimondo SEC EDGAR Filings (CIK 0002005618)

SEC EDGAR filings, ownership reports, and insider transactions for Thomas DiRaimondo.

Business address
C/O Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA, 92130
Top holdings (ownership)
JANX
Get insider transactions for this reporting owner
Thomas DiRaimondo has filed 6 SEC EDGAR filings since 03 Jan 2024

Latest Filings

Recent SEC filings for Thomas DiRaimondo including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 02 Jan 2026 02 Jan 2026 001-40475
4 Open 4 document View SEC filing for 4 03 Jan 2025 02 Jan 2025 001-40475
4 Open 4 document View SEC filing for 4 27 Sep 2024 27 Sep 2024 001-40475
144 Open 144 document View SEC filing for 144 27 Sep 2024
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jan 2024 02 Jan 2024 001-40475
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Jan 2024 01 Jan 2024 001-40475

About this filer

Thomas DiRaimondo files with the SEC under CIK 0002005618. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages